<code id='C9A6FAE537'></code><style id='C9A6FAE537'></style>
    • <acronym id='C9A6FAE537'></acronym>
      <center id='C9A6FAE537'><center id='C9A6FAE537'><tfoot id='C9A6FAE537'></tfoot></center><abbr id='C9A6FAE537'><dir id='C9A6FAE537'><tfoot id='C9A6FAE537'></tfoot><noframes id='C9A6FAE537'>

    • <optgroup id='C9A6FAE537'><strike id='C9A6FAE537'><sup id='C9A6FAE537'></sup></strike><code id='C9A6FAE537'></code></optgroup>
        1. <b id='C9A6FAE537'><label id='C9A6FAE537'><select id='C9A6FAE537'><dt id='C9A6FAE537'><span id='C9A6FAE537'></span></dt></select></label></b><u id='C9A6FAE537'></u>
          <i id='C9A6FAE537'><strike id='C9A6FAE537'><tt id='C9A6FAE537'><pre id='C9A6FAE537'></pre></tt></strike></i>

          hotspot

          hotspot

          author:Wikipedia    Page View:5
          A sign of AdventHealth on its building in Orlando, Florida — coverage from STAT
          Adobe

          A lawsuit between a large hospital system and a dominant vendor that works for health insurance companies is getting a lot more heated — with one party calling the other an “economic parasite.”

          The suit, between nonprofit hospital giant AdventHealth and MultiPlan, is now even attracting rare interest from the nation’s biggest hospital lobbyists.

          advertisement

          The new, highly detailed legal filings also come right as MultiPlan and more than a dozen of the largest tax-exempt, nonprofit hospital systems are wooing investors at the J.P. Morgan Healthcare Conference. AdventHealth did not attend this year’s conference, but did so last year.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          FDA greenlights medical device to combat bladder issues
          FDA greenlights medical device to combat bladder issues

          AndrewHarnik/APYou’rereadingthewebeditionofSTATHealthTech,ourguidetohowtechistransformingthelifescie

          read more
          23andMe had bad news about my health. I wish a person had delivered it
          23andMe had bad news about my health. I wish a person had delivered it

          ERICBARADAT/AFP/GettyImagesLastsummer,IthoughtitmightbefuntohavemyDNAanalyzed.Twocompanies,23andMean

          read more

          A Q&A with the global head of Boehringer Ingelheim's innovation unit

          MichelPairetCourtesyBoehringerIngelheimLONDON—Ataneventherelastweek,theGermanpharmaceuticalfirmBoehr